Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals and Financings

Set Alert for Deals

VC Deals Analysis: Positive Exit Markets Keep Venture Investment Swell Growing

Big-buck rounds of over $100m seem to be becoming the standard – rather than one-offs – in the medtech venture financing scene, with yet another two of these nine-figure transactions recorded in April. These mega rounds, together with the healthy deal volume seen that month, boosted total deal value to nearly $700m.

Deals Financing StartUps and SMEs
Advertisement

Latest From Deals

Philips Joins AHA, UPMC To Invest In Heart Disease, Stroke Innovation

Philips has teamed up for the first time with the American Heart Association and the University of Pittsburgh Medical Center to set up a $30m venture capital fund that will invest in start-ups that are developing solutions to combat heart disease and stroke.

Cardiology Neurology

Medtech Money Flow: Weekly M&A and VC Deals, May 7-13, 2018

In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced May 7-13, 2018.

Commercial Deals

M&A Analysis: Volume Shrinks In April But Value Inflated By Big Acquisitions

Medtech M&A activity dipped in April from last month but brought in a number of high-value acquisitions. Highlights included Fresenius, the world's largest dialysis firm, selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15bn to investment firm Summit Partners. 

Deals M & A

Pacts In Medtech, March/April 2018

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech highlights notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we look at industry pacts that were sealed in March and April 2018.

Pacts in Medtech Deals

Permira Inks Deal To Buy Orthopedics Firm Corin

Permira has signed a deal to acquire a majority stake in orthopedics group Corin from a group of investors for an undisclosed price.

Orthopedics M & A

Medtech Money Flow: Weekly M&A and VC Deals, April 30-May 6, 2018

In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced April 30-May 6, 2018.
M & A Financing

BioTrinity 2018: Bullish M&A And IPO Outlook; Spotlight On Eyevensys, Rexgenero

Industry experts, investors and start-ups from across the pharma, biotech and medtech sectors gathered at the recent annual BioTrinity conference held in London to hear how the capital-raising climate is looking rosy for 2018, and to explore partnering and investment opportunities. Medtech Insight reports on predicted trends in health care and highlights two companies, Eyevensys and Rexgenero, that were presenting at the conference. 

Innovation Financing

Medtech Money Flow: Weekly M&A and VC Deals, April 23-29, 2018

In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced April 23-29, 2018.

Deals Financing

MicroPort Swoops In On Bankrupt Lombard Medical

Chinese medtech group MicroPort Scientific has bagged another cardiology deal this year, this time buying up its UK aortic valve repair partner Lombard Medical, which has run aground after failing to navigate itself out of financial troubles.

Cardiology Commercial
See All
UsernamePublicRestriction

Register